Skip to main content
. 2018 Aug 28;12(2):369. doi: 10.4081/oncol.2018.369

Table 3.

Preferable adjuvant treatment regimens of participant surgeons.

Adjuvant treatment regimen n (%), total n=112
Fluorouracil and cisplatin 2 (1.8)
ECF (epirubicin, cisplatin, and fluorouracil) 0 (0)
S-1 57 (50.9)
Capecitabine and oxaliplatin 35 (31.3)
Fluorouracil and leucovorin with radiation 12 (10.7)
Fluorouracil and oxaliplatin with radiation 5 (4.5)
Other 1 (0.8)